People · Operator
Named in public records as an officer, director or promoter · active 2011–2017 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SynGen Inc. | — | Biotechnology | Seed | $15.2M | $17.8M | 2012 |
| Ampio Pharmaceuticals, Inc. | — | Pharmaceuticals | Pre-Seed | $585K | $27.7M | 2011 |
Philip H. Coelho at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Philip H. Coelho on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Macaluso | 1 | 4 |
| Bruce G Miller | 1 | 2 |
| William H. Gerber | 1 | 1 |
| Vic H. Schmitt | 1 | 1 |
| Chuck A. Novak | 1 | 1 |
| Carl A. Goldfischer | 1 | 1 |
| Woodrow A. Myers, Jr. | 1 | 1 |
| Richard H Giles | 1 | 1 |
| Vaughan H Clift | 1 | 1 |
| Donald B Wingerter, Jr. | 1 | 1 |
| David B Bar-Or | 1 | 1 |
| George H. Barry | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.